Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 9/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 7/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 6/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 1.00 |
| ▸ | XDH | P47989 | 4/20 | 1.00 |
| ▸ | IPMK | Q8NFU5 | 4/20 | 1.00 |
| ▸ | IP6K2 | Q9UHH9 | 4/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 1.00 |
| ▸ | PPARG | P37231 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 2/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.76 |
| ▸ | NOX4 | Q9NPH5 | 3/20 | 0.74 |
| ▸ | FTO | Q9C0B1 | 3/20 | 0.73 |
| ▸ | MAOA | P21397 | 2/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.72 |
| ▸ | MAPT | P10636 | 6/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isorhamnetin SCHEMBL30385934 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Isorhamnetin SCHEMBL19235 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Isorhamnetin SCHEMBL29390102 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Isorhamnetin SCHEMBL28182051 | 0.96 | MEN1 (0.93) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Isorhamnetin SCHEMBL3715283 | 0.96 | MEN1 (0.93) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| SCHEMBL3211188 | 0.93 | MEN1 (0.86) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| SCHEMBL29575749 | 0.93 | MEN1 (0.86) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| SCHEMBL29442903 | 0.93 | MEN1 (0.86) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| SCHEMBL30256517 | 0.93 | MEN1 (0.86) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Rhamnazin SCHEMBL39443 | 0.91 | MEN1 (0.84) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250351836-A1 | SEED EXTRACT FOR USE DURING FOOD COOKING AND STORAGE PROCESSES | Khalifa University of Science and Technology (AE) | 2025-11-20 | — | — | US | claimed |
| CN-119019999-A | Electric automobile cooling liquid and preparation method thereof | 上海德联化工有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-115315195-B | Hydroxy-and methoxy-substituted flavonoids and use thereof | 弗门尼舍有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-115315195-A | Hydroxy-and methoxy-substituted flavonoids and their use | 弗门尼舍有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114040986-A | Method of diagnosing disease | 4D制药科克有限公司 | 2022-02-11 | — | — | CN | claimed |
| US-20250351836-A1 | SEED EXTRACT FOR USE DURING FOOD COOKING AND STORAGE PROCESSES | Khalifa University of Science and Technology (AE) | 2025-11-20 | — | — | US | disclosed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | disclosed |
| CN-119367384-B | Application of quercetin derivative Q3MG in preparation of anti-tumor invasion and metastasis drugs | 芙蓉实验室 | 2025-04-08 | — | — | CN | disclosed |
| WO-2025038482-A2 | USE OF FISETIN FOR REDUCING THE INCIDENCE OF ATRIAL FIBRILLATION | RHODE ISLAND HOSPITAL (US) | 2025-02-20 | — | — | WO | disclosed |
| US-20250041318-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | COMMUNITREAT LTD. (IL) | 2025-02-06 | — | — | US | disclosed |
| CN-119367384-A | Application of quercetin derivative Q3MG in preparation of anti-tumor invasion and metastasis drugs | 芙蓉实验室 | 2025-01-28 | — | — | CN | disclosed |
| US-20240398715-A1 | ORAL SOFT CAPSULE THAT ENCAPSULATES A NALBUPHINE FORMULATION | PHYTOHEALTH CORPORATION (TW) | 2024-12-05 | — | — | US | disclosed |
| EP-4210656-A1 | SENOLYTIC COMPOUNDS AND COMPOSITIONS | Nuchido Limited (GB) | 2023-07-19 | — | — | EP | disclosed |
| WO-2023100184-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | COMMUNITREAT LTD. (IL) | 2023-06-08 | — | — | WO | disclosed |
| CN-116036073-A | Application of isorhamnetin in preparation of drugs for inducing nasopharyngeal carcinoma cells to undergo side apoptosis | 广东医科大学 | 2023-05-02 | — | — | CN | disclosed |
| CN-115315195-A | Hydroxy-and methoxy-substituted flavonoids and their use | 弗门尼舍有限公司 | 2022-11-08 | — | — | CN | disclosed |
| WO-2022189156-A1 | HYDROXY- AND METHOXY-SUBSTITUTED FLAVONOIDS AND THEIR USE | FIRMENICH SA (CH) | 2022-09-15 | — | — | WO | disclosed |
| CN-114699401-A | Application of isorhamnetin in preparation of thoracic aorta vasodilation drugs | 宁夏医科大学 | 2022-07-05 | — | — | CN | disclosed |
| WO-2022053800-A1 | SENOLYTIC COMPOUNDS AND COMPOSITIONS | Nuchido Limited (GB) | 2022-03-17 | — | — | WO | disclosed |
| CN-114040986-A | Method of diagnosing disease | 4D制药科克有限公司 | 2022-02-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | S100A8, TP53, AQP1 | MEN1 312/4885KMT2A 4248/4885CYP1A2 4394/4885 |
| US-20240398715-A1 | ORAL SOFT CAPSULE THAT ENCAPSULATES A NALBUPHINE FORMULATION | TREH, SORD, SYMPK | MEN1 1726/4885KMT2A 2209/4885CYP1A2 1633/4885 |
| US-20250041318-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | NASP, ACR, ALPG | MEN1 743/4885KMT2A 1588/4885CYP1A2 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.